At this time, the firm appears to be overvalued. Humana Inc retains a regular Real Value of USD246.25 per share. The prevalent price of the firm is USD297.99. Our model calculates the value of Humana Inc from evaluating the firm fundamentals such as Return On Asset of 0.0401, return on equity of 0.0784, and Current Valuation of 25.23 B as well as inspecting its technical indicators and probability of bankruptcy.
Enterprise Value
25.2 B
Price Sales
0.3634
Trailing PE
0.1264
Overvalued
Today 297.99
Please note that Humana's price fluctuation is very steady at this time. Calculation of the real value of Humana Inc is based on 3 months time horizon. Increasing Humana's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Humana stock is determined by what a typical buyer is willing to pay for full or partial control of Humana Inc. Since Humana is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Humana Stock. However, Humana's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical
Market 297.99
Real 246.25
Hype 295.13
Naive 305.45
The intrinsic value of Humana's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Humana's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Humana Inc helps investors to forecast how Humana stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Humana more accurately as focusing exclusively on Humana's fundamentals will not take into account other important factors:
Humana Inc is presently projected to have takeover price of 25.23 B with market capitalization of 3.86 T, debt of 10.21 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Humana fundamentals before making investing decisions based on enterprise value of the company
About 95.0% of the company shares are owned by institutions such as pension funds. The company recorded earning per share (EPS) of 23.55. Humana Inc had not issued any dividends in recent years. Based on the key measurements obtained from Humana's financial statements, Humana Inc is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Humana has an asset utilization ratio of 226.85 percent. This implies that the Company is making USD2.27 for each dollar of assets. An increasing asset utilization means that Humana Inc is more efficient with each dollar of assets it utilizes for everyday operations.
Yuan Drop
Covid
Humana Ownership Allocation
Humana Inc has a total of 137.19 Million outstanding shares. The majority of Humana Inc outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Humana to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Humana Inc. Please pay attention to any change in the institutional holdings of Humana Inc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Humana Profitability Analysis
The company reported the revenue of 106.37 B. Net Income was 2.49 B with profit before overhead, payroll, taxes, and interest of 17.18 B.
About Humana Valuation
The stock valuation mechanism determines Humana's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Humana Inc based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Humana. We calculate exposure to Humana's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Humana's related companies.
When running Humana's price analysis, check to measure Humana's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Humana is operating at the current time. Most of Humana's value examination focuses on studying past and present price action to predict the probability of Humana's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Humana's price. Additionally, you may evaluate how the addition of Humana to your portfolios can decrease your overall portfolio volatility.